Last Updated: 2021-10-15
Mainly adults are affected. Patients tend to infect themselves with a tinea pedum or nail mycosis.
- Trichophyton rubrum (large majority)
- Trichophyton mentagrophytes (about 10%)
- Epidermophyton floccosum (about 4%)
- Microsporum canis
- Microsporum gypseum
- In most cases the transmission is caused by fungal infections at other locations
- The back of the hands and fingers, the interdigital space and the palms of the hands can be affected. Usually erythematous, scaly, hyperkeratotic-rhagadiform plaques appear.
- There is an association with the Tinea barbae.
- Clinical features
- Pathogen detection (hair removal or dandruff extraction: then native preparation and culture; biopsy)
Usually only on one hand, can be on both sides.
- If zoophilic dermatophytes are detected, all animals with which contact has existed should be examined.
- Examination of other people in the household.
- The therapy should be carried out with both topical and systemic antifungals!
Itraconazole p.o. 200 mg 1x daily
Alternatively: Fluconazole p.o. 50 mg 1x daily
Alternatively: Terbinafine p.o. 250 mg 1x daily
Children: Although only Griseofulvin is approved for children, we rather recommend the use of Itraconazole
- Lachapelle JM, De Doncker P, Tennstedt D, Cauwenbergh G, Janssen PA. Itraconazole compared with griseofulvin in the treatment of tinea corporis/cruris and tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile. Dermatology 1992;184:45-50.
- Bourlond A, Lachapelle JM, Aussems J, et al. Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea corporis and tinea cruris. Int J Dermatol 1989;28:410-2.